Aptevo Therapeutics Inc. (NASDAQ: APVO) announced today the receipt of a $4.3 million milestone payment from Saol International Limited (Saol) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News Management Comments

Aptevo Therapeutics (APVO) Tops Q2 EPS by 3cAugust 9, 2019 9:02 AM Aptevo Therapeutics Receives $4.3 Million Milestone Payment From Saol International LimitedAugust 7, 2019 9:02 AM